SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.351 Beta). Extracted from infectious cell culture supernatant. Product only available via TNA.
SARS-COV-2 Lyophilised RNA, HUMAN, 2022, GERMANY (LINEAGE BA.5, OMICRON). Extracted from infectious cell culture supernatant. Product only available via TNA.
SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.621, Mu). Extracted from infectious cell culture supernatant. Product only available via TNA.
SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.1.318). Extracted from infectious cell culture supernatant. Product only available via TNA.
SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.617.1, Kappa). Extracted from infectious cell culture supernatant. Product only available via TNA.
SARS-COV-2 Lyophilised RNA, HUMAN, 2021, GERMANY (LINEAGE B.1.1.7 Alpha). Extracted from infectious cell culture supernatant. Product only available via TNA.
This product represents cDNA material, transcribed with random hexamers from total RNA extracted from the viral stock of SARS-CoV-2 strain Slovakia/SK-BMC5/2020 which is available as a viable virus under Ref-SKU: 006V-03933.
Vial containing RNA of SARS-CoV-2 (hCoV-19/Netherlands/NH-EMC-1720/2021, Omicron variant, lineage B.1.1.529. This strain has been cultivated on Calu-3 cells. . GSAID reference: hCoV-19/Netherlands/NH-RIVM-71084/2021.
In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the E gene .
Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from:
https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2
Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045
In vitro transcribed RNA for Wuhan coronavirus (2019-nCoV) real time (RT-)PCR targeting region of the RdRP gene .
Protocol and preliminary evaluation for this assays (Corman/Drosten 2020), as of Jan 13, 2020, available from:
https://www.who.int/docs/default-source/coronaviruse/protocol-v2-1.pdf?sfvrsn=a9ef618c_2
Ref: https://www.eurosurveillance.org/content/10.2807/1560-7917.ES.2020.25.3.2000045
This product represents total RNA extracted from the viral stock of SARS-CoV-2 strain Slovakia/SK-BMC5/2020 which is available as a viable virus under Ref-SKU: 006V-03933.
In vitro transcribed RNA for new Betacoronavirus virus (hCoV-EMC) real time PCR targeting region upstream of the E gene (upE). Reference: Corman et. Al., Eurosurveillance, Volume 17, Issue 39, 27 September 2012
In vitro transcribed RNA for new Betacoronavirus virus (hCoV-EMC) real time PCR targeting region within the open reading frame 1a. Reference: Corman/Mueller et al., Eurosurveillance, Volume 17, Issue 49, 06 December 2012
N-terminal domain of the SARS-CoV-2 nucleprotein (1-180). Pure recombinant protein produced in E. coli and fused with a Avi tag and a Hexa-Hisitidine tag.
C-terminal domain of the SARS-CoV-2 nucleprotein (247-418). Pure recombinant protein produced in E. coli and fused with a Avi tag and a Hexa-Hisitidine tag.
The in vitro transcribed RNA is the control for the first-line screening assay termed E gene assay. The SARS-CoV full virus RNA is required to control the two confirmatory assays. Dislaimer: Import permit maybe be needed in your country for the SARS-CoV full virus RNA. If yes, please indicate so in your online enquiry.